Triple
T14372217
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Samsung |
E356383
|
entity |
| Predicate | subsidiary |
P258
|
FINISHED |
| Object | Samsung Biologics |
E72266
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Samsung Biologics | Statement: [Samsung, subsidiary, Samsung Biologics]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Samsung Biologics Context triple: [Samsung, subsidiary, Samsung Biologics]
-
A.
Samsung Biologics
chosen
Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
-
B.
Samsung Bioepis
Samsung Bioepis is a South Korean biopharmaceutical company specializing in the development and commercialization of biosimilar medicines.
-
C.
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
-
D.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
E.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8279163a081908aec45c0e3f1e02f |
completed | April 9, 2026, 10:26 p.m. |
| NER | Named-entity recognition | batch_69de8fb2082c8190b42cc5f2bab4f574 |
completed | April 14, 2026, 7:04 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fd4c5363a081909681b54c1d8218dc |
completed | May 8, 2026, 2:37 a.m. |
Created at: April 10, 2026, 1:15 a.m.